Action NanoViricides - NNVC

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

1,45

Prix Achat

Prix Vente

Volume échangé

308 550

1,41 Fourchette du Jour 1,50

0,94 Plage de 52 semaines 2,55

Cap du marché

23,304M

Clôture Veille

1,36

Ouverture

1,44

Dernière Transaction

1829

1.43

Dernière heure de transaction

Volume financier

US$ 444 446

VWAP

1,4404

Volume moyen (3 m)

164 797

Actions en circulation

16 072 000

Rendement du Dividende

Ratio Cours sur Bénéfices

-2,77

Bénéfice par action (BPA)

-0,52

Chiffre d'affairess

Bénéfice net

-8,29M

Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex iss... Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through an in-licensing strategy. Show more

Secteur

Pharmaceutical Preparations

Industrie

Coml Physical, Biologcl Resh

Site Web

www.nanoviricides.com

Siège social

Reno, Nevada, USA

Fondé

2005

NanoViricides Inc est coté dans le secteur Pharmaceutical Preparations de la American Stock Exchange avec le ticker NNVC. Le dernier cours de clôture d'NanoViricides était de US$1,36. Au cours de la dernière année, les actions de NanoViricides ont été négociées dans une fourchette de prix de US$ 0,94 à US$ 2,55.

NanoViricides compte actuellement 16 072 000 actions en circulation. La capitalisation boursière d'NanoViricides est de US$21,86 million. NanoViricides a un ratio cours/bénéfice (ratio PE) de -2.77.

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.07	-4.60526315789	1.52	1.54	1.25	206163	1.43189956	CS
4	-0.03	-2.02702702703	1.48	1.9195	1.25	258413	1.60515897	CS
12	0.21	16.935483871	1.24	1.9195	0.94	164797	1.45315729	CS
26	0.02	1.3986013986	1.43	1.9195	0.94	252566	1.38508741	CS
52	-0.31	-17.6136363636	1.76	2.55	0.94	234666	1.55959607	CS
156	-0.56	-27.8606965174	2.01	3.88	0.94	169636	2.15831595	CS
260	-5.3	-78.5185185185	6.75	10.88	0.94	475875	5.17195295	CS

NNVC - Frequently Asked Questions (FAQ)

What is the current NanoViricides share price?

The current share price of NanoViricides is US$ 1,45

How many NanoViricides shares are in issue?

NanoViricides has 16 072 000 shares in issue

What is the market cap of NanoViricides?

The market capitalisation of NanoViricides is USD 21,86M

What is the 1 year trading range for NanoViricides share price?

NanoViricides has traded in the range of US$ 0,94 to US$ 2,55 during the past year

What is the PE ratio of NanoViricides?

The price to earnings ratio of NanoViricides is -2,77

What is the reporting currency for NanoViricides?

NanoViricides reports financial results in USD

What is the latest annual profit for NanoViricides?

The latest annual profit of NanoViricides is USD -8,29M

What is the registered address of NanoViricides?

The registered address for NanoViricides is 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501

What is the NanoViricides website address?

The website address for NanoViricides is www.nanoviricides.com

Which industry sector does NanoViricides operate in?

NanoViricides operates in the COML PHYSICAL, BIOLOGCL RESH sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
AIMAIM ImmunoTech Inc	US$ 9,3008 (9 700,63%)	87,17k
MITQMoving iMage Technologies Inc	US$ 0,82 (48,26%)	190,7M
SYNXSilynxcom Ltd	US$ 2,07 (21,76%)	818,13k
GNSGenius Group Limited	US$ 0,5408 (20,71%)	66,94M
MPUMega Matrix Inc	US$ 1,07 (20,22%)	711,94k
HUSAHouston American Energy Corp	US$ 14,85 (-15,14%)	2,13M
RYDERyde Group Ltd	US$ 0,388 (-13,78%)	11,7M
MXCMexco Energy Corp	US$ 11,3961 (-13,07%)	35,33k
RODEHartford Multifactor Diversified International ETF	US$ 27,57 (-12,81%)	218
CVRChicago Rivet and Machine Co	US$ 11,8801 (-12,00%)	3,73k
MITQMoving iMage Technologies Inc	US$ 0,82 (48,26%)	190,7M
DNNDenison Mines Corp	US$ 1,73 (-5,98%)	171,46M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 21,21 (-1,85%)	137,08M
SOXSDirexion Daily Semiconductor Bear 3X Shares New	US$ 9,54 (2,03%)	133,55M
SPYSPDR S&P 500	US$ 594,28 (-0,53%)	94,05M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

NanoViricides Inc (NNVC)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de NanoViricides Inc

NNVC Dernières nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form DEF 14A - Other definitive proxy statements

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form DEF 14A - Other definitive proxy statements

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

NNVC - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

NanoViricides Inc (NNVC) Cours

NanoViricides Inc (NNVC)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de NanoViricides Inc

NNVC Dernières nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form DEF 14A - Other definitive proxy statements

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form DEF 14A - Other definitive proxy statements

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

NNVC - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Connectez-vous

Supprimer les publicités